Weekly CEO News from Richard Ingram
April 11, 2017

It’s a new world in the payer community, and…peak sales projections seem to be further off the mark than ever as the commercial kickback grows steadily worse but it is always interesting to see what analysts believe the big new

Read more

Fundamental Analysis of Gold As we often point out in these pages, even though gold is currently not the generally used medium of exchange, its monetary characteristics continue to be the main basis for its valuation. Thus, analysis of the

Read more

It’s always been a tough call to make when trying to pick a more promising investment bet from among Canada’s banking majors, especially the top two – the Royal Bank of Canada (NYSE:RY) and the Toronto-Dominion Bank (NYSE:TD). By Vasudha Sharma

Read more

Stocks sold off in early trading as bonds got bid up to a key level. Short term volatility continued to get bid up as the APR volatility futures contracts are now a full 1.50 points higher than May volatility. Despite

Read more

With the technicals on the stock market weakening ever so subtly, I concluded that now might be a good time to lock in the rest of my profits on the seasonal trade on home builders. However, an upgrade from RBC on Toll

Read more

Nervous markets again with US military positioning headlines for most of the session and that led to safety moves back into the JPY. Having broken the 111 handle early, next target was the 110 handle. Many did not expect the

Read more

Neurocrine Bioscience, Inc. (NBIX) has received FDA approval for its branded drug Ingrezza (valbenazine) for the treatment of tardive dyskinesia, setting up a potential showdown just a week after Teva (TEVA) scored with their rival therapy, now approved for Huntington’s chorea. Written

Read more

The current silver price trend is once again at a critical juncture. It has been four years since the price of silver crossed an important trend line. However, the present setup will result in either another correction lower, or a

Read more

The end of 2017’s Q1 draws to close a quarter that saw the bull market ushering in its ninth year and politics domestic and abroad impacting markets in the United States and beyond. The New Administration & the Markets Politics

Read more

(Photo Credit: Bernal Saborio) Delta Air Lines (DAL): Industrials – Airlines | Reports April 12, Before Market Opens Key Takeaways The Estimize consensus is looking for EPS of $0.74, 1 cent above Wall Street, with revenue expectations of $9.176 billion, $20M ahead

Read more